A detailed history of Alpha Centric Advisors LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 15,500 shares of JAZZ stock, worth $1.73 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares
15,500
Previous 11,000 40.91%
Holding current value
$1.73 Million
Previous $1.17 Million 47.1%
% of portfolio
1.46%
Previous 0.97%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$100.57 - $116.37 $452,564 - $523,665
4,500 Added 40.91%
15,500 $1.73 Million
Q2 2024

Jul 25, 2024

BUY
$103.94 - $118.98 $259,850 - $297,450
2,500 Added 29.41%
11,000 $1.17 Million
Q1 2024

Apr 24, 2024

SELL
$115.19 - $132.77 $230,380 - $265,540
-2,000 Reduced 19.05%
8,500 $1.02 Million
Q4 2023

Feb 14, 2024

SELL
$114.26 - $136.0 $1.83 Million - $2.18 Million
-16,000 Reduced 60.38%
10,500 $1.29 Million
Q3 2023

Nov 13, 2023

SELL
$122.0 - $145.31 $1.74 Million - $2.07 Million
-14,250 Reduced 34.97%
26,500 $3.43 Million
Q2 2023

Aug 08, 2023

BUY
$122.5 - $147.16 $4.13 Million - $4.97 Million
33,750 Added 482.14%
40,750 $5.05 Million
Q1 2023

May 12, 2023

BUY
$133.98 - $160.47 $468,929 - $561,645
3,500 Added 100.0%
7,000 $1.02 Million
Q3 2022

Nov 08, 2022

SELL
$126.59 - $161.18 $822,835 - $1.05 Million
-6,500 Reduced 65.0%
3,500 $467,000
Q4 2021

Feb 25, 2022

BUY
$119.87 - $145.67 $1.2 Million - $1.46 Million
10,000 New
10,000 $1.27 Million
Q4 2020

Mar 11, 2022

SELL
$140.71 - $165.05 $49,248 - $57,767
-350 Closed
0 $0
Q3 2020

Mar 11, 2022

SELL
$105.46 - $144.13 $29,001 - $39,635
-275 Reduced 44.0%
350 $50,000
Q2 2020

Mar 11, 2022

BUY
$95.68 - $121.88 $59,800 - $76,175
625 New
625 $69,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.01B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.